Multiwavelength videomicrofluorometric study of some human leukemic lymphoblasts: Effect of adriamycin on some biological parameter

Anticancer Research

Volumn 18, Issue 2 A, 1998, Pages 1091-1097

  Rocchi, Emmanuelle ^a   Vigo, Jean ^a   Viallet, Pierre ^a   Salmon, Jean Marie ^a  

^a UNIVERSITÉ DE PERPIGNAN   (France)

Author keywords

Adriamycin; Biological parameters; Chemotherapy; Cytotoxicity; Multidrug resistance; Multiparametric analysis

Indexed keywords

DOXORUBICIN; GLYCOPROTEIN P; HOE 33342; RHODAMINE 123;

ARTICLE; CELL STRUCTURE; CONTROLLED STUDY; DRUG CYTOTOXICITY; HUMAN; HUMAN CELL; IMAGE ANALYSIS; LEUKEMIA CELL; LYMPHOBLAST; MICROFLUOROMETRY; MITOCHONDRION; MULTIDRUG RESISTANCE; PHENOTYPE; PRIORITY JOURNAL;

EID: 0031811968     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Riordan JR and Ling V: Genetic and biochemical characterization of multidrug resistance. Pharmac Ther 28: 51-75, 1985.
2. Isuruo T: Mechanisms of multidrug resistance and implications for therapy. Jpn J Cancer Res 79: 285-296, 1988.
3. Le Bot MA, Kermalegen D, Roert J, Berlion M and Riche C: Modulation of anthracycline accumulation and metabolism in rat hepatocytes in culture by three revenants of multidrug resistance. Cancer Chemotherapy Pharmacol 35: 53-58, 1994.
4. Abraham EH, Prat AG, Gerweck L, Seneveratne T, Arceci RJ, Kramer R, Guidotti J, and Cantiello HF: Is the multidrug resistance an ATP channel? Hepatology 18: 216-222, 1993.
5. Gill DR, Hyde SC, Higguis CF, Valverde MA, Mintening GM and Sepulveda FV: Separation of drug transport and chloride channel functions of the human multidrug resistance P-glycoprotein. Cell 71: 23-32, 1992.
6. Zaman GJR, Flens MJ, Van Leusden MR, De Haas M, Mulder HS, Lankelma J, Pinedo HM, Scheper RJ, Baas F, Broxterman HJ and Borst, P: The human multidrug resistance- associated protein MRP is a plasma membrane drug-efflux pump. Proc Natl Acad Sei USA 91: 8822-8826, 1994.
7. Riordan JR, Deuchars K, Kartner N, Alon N, Trent J and Ling V: Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines. Nature 316: 817-819, 1985.
8. Gottesman MM and Pastan I: The multidrug transporter, a double-edged sword. J Biol Chem 263: 12163-12166, 1988.
9. Essential drugs for cancer chemotherapy. Bulletin of the world Health Organization 72: No.5, 694-698,1994.
10. Lahmy S, Viallet P and Salmon JM: Is reduced accumulation of Hoechst 33342 in multidrug resistant cells related to P-glycoprotein activity ? Cytometry 19: 126-133, 1995.
11. Latt S and Stetten G: Spectral studies on 33258 Hoechst and related bisbenzimidazole dyes useful for fluorescent detection of deoxyribonucleic acid synthesis. J Histochem Cytochem 24: 24-33, 1976.
12. Johnson LV, Walsh ML and Chen LB: Localization of mitochondria in living cells with Rhodamine 123. Proc Natl Sci USA, 77: 990-994, 1980.
13. Darzynkiewicz Z, Staiano-Coico L and Melamed MR: Increased mitochondrial uptake of rhodamine 123 during Iymphocyte stimulation. Proc Natl Acad Sci USA 78: 2383, 1981.
14. Canitrot Y, Lautier D, Lahmy S, Vigo J, Viallet P and Salmon JM: Nile Red labeling of single living cells for contour delineation to quantify and evaluate the distribution of rhodamine 123 with fluorescence image cytometry. J Histochem Cytochem 14: 1785-1793, 1993.
15. Katalin G, Laszlo B, Terez M, Lajos T, Adorjan A and Gabor SJr: Intracellular pH does not effect drug extrusion by P-glycoprotein. J Photochem Photobiol Biol 34: 177-182, 1996.
16. Simon S, Roy D and Schindler M: Intracellular pH and the control of multidrug resistance. Cell Biology 91: 1128-1132, 1994.
17. Haugland RP: Handbook of fluorescence probes and research chemicals, sixth edition, Molecular Probes Inc. Eugene OR.pp.556 1996.
18. Beck WT, Cirtain MC, Look AT and Ashum RA: Reversal of Vinca Alkaloid-resistance but not multidrug resistance in human leukemia cells by verapamil. Cancer Res 46: 778-784, 1986.
19. Danks MK, Yalowitch JC and Beck WT: (1986) Atypical multiple drug resistance in a human leukemia cell line selected for resistance to Teniposide (VM-26). Cancer Res 47: 1297-1301, 1986.
20. Beck WT, Mueller JT and Tanzer LR: Altered surface membrane glycoprotein in Vinca Alkaloid-resistant human leukemic lymphoblasts. Cancer Res 39: 2070-2076, 1979.
21. Vigo J, Salmon JM, Lahmy S, and Viallet P: Fluorescent image cytometry: from qualitative to quantitative measurement. Anal Cell Pathol 3: 145-165, 1991.
22. Salmon JM, Lautier D, Lahmy S, Vigo J and Viallet P: Multiwavelength videomicrofluorometry and multiparametric analysis: application to the detection of multidrug- resistance in single living cells. J Cell Pharmacol, 3: 86-94, 1992.
23. Arancia G, Bordi F, Calcabrini A, Diociaiuti M and Molinari A: Ultrastructural and spectroscopic methods in the study of anthracycline-membrane interaction. Parmacol Res 32: 255-272, 1995.
24. Grunicke H and Hofmann J: Cytotoxic and cytostatic effects of antitumor agents induced at the plasma membrane level. Pharmac Ther 55: 1-30, 1992.
25. Lautier D, Lahmy S, Canitrot Y, Vigo J, Viallet P and Salmon JM: Detection of leukemia cells with multidrug resistance phenotype using multilabelling with fluorescent dyes. Anticancer Res 13: 1557-1564, 1995.
26. Lahmy S, Salmon JM, Vigo J and Viallet P: PHi and DNA content modifications after ADR treatment in 3T3 fibroblasts. A microfluorometric approach. Anticancer Res 9: 929-936, 1989.